Sale!

LMNA Gene Emery-Dreifuss muscular dystrophy type 2 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the LMNA gene, which are associated with Emery-Dreifuss Muscular Dystrophy Type 2 (EDMD2). EDMD2 is a rare genetic condition characterized by muscle weakness and wasting, joint contractures, and heart problems, often leading to significant physical disability and cardiac issues. This test plays a critical role in the early detection and management of the disease, enabling healthcare providers to tailor treatments and interventions more effectively.

Priced at 4400 AED, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for specific genetic mutations in the LMNA gene. Positive identification of these mutations can confirm a diagnosis of EDMD2, allowing for early and more precise medical and therapeutic interventions. Given the complexity of the disease and the importance of early diagnosis in managing symptoms and improving quality of life, the LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 Genetic Test is a valuable resource for individuals exhibiting symptoms of the disease or those with a family history of EDMD2.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 Genetic Test

Are you concerned about Emery-Dreifuss muscular dystrophy type 2 (EDMD2)? DNA Labs UAE offers the LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 Genetic Test to help diagnose this rare genetic disorder.

Test Components and Price

The LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 Genetic Test costs AED 4400.0. The test requires a blood sample, extracted DNA, or one drop of blood on an FTA card.

Report Delivery and Method

After the sample is collected, the report will be delivered within 3 to 4 weeks. The test utilizes NGS (next-generation sequencing) technology to analyze the patient’s DNA.

Test Type and Doctor

The LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 Genetic Test falls under the category of neurological disorders. It is recommended to consult with a neurologist for this test.

Test Department and Pre-Test Information

The test is conducted in the genetics department. Before undergoing the LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by EDMD2.

Test Details

Emery-Dreifuss muscular dystrophy type 2 (EDMD2) is a rare genetic disorder characterized by muscle weakness and wasting, joint contractures, and cardiac abnormalities. The LMNA gene is associated with this condition. The LMNA Gene Emery-Dreifuss Muscular Dystrophy Type 2 Genetic Test uses NGS technology to identify mutations in the LMNA gene that cause EDMD2. By analyzing the patient’s DNA, the test can detect any changes or mutations in the LMNA gene, confirming a diagnosis of EDMD2 and guiding treatment and management options.

Test Name LMNA Gene Emery-Dreifuss muscular dystrophy type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for LMNA Gene Emery-Dreifuss muscular dystrophy type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with LMNA Gene Emery-Dreifuss muscular dystrophy type 2
Test Details

The LMNA gene is associated with Emery-Dreifuss muscular dystrophy type 2 (EDMD2), which is a rare genetic disorder characterized by muscle weakness and wasting, joint contractures, and cardiac abnormalities. NGS (next-generation sequencing) genetic testing can identify mutations in the LMNA gene that cause EDMD2. This test involves analyzing a patient’s DNA to detect any changes or mutations in the LMNA gene. If a mutation is identified, it can confirm a diagnosis of EDMD2 and help guide treatment and management options.